SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > 22nd Century Group (XXII)

"Positive Phase III results are a significant and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Justfactsmam Member Profile
 
Followed By 71
Posts 5,732
Boards Moderated 0
Alias Born 02/09/12
160x600 placeholder
22nd Century Completes Successful Hemp Field Trials with University of Virginia "Business Wire" - 10/19/2017 9:45:00 AM
Mounting Evidence on Therapeutic Benefits of Cannabis Unleashes Tsunami "NetworkNewsWire" - 10/18/2017 8:45:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 10/17/2017 9:51:18 AM
22nd Century Group Closes $54 Million Common Stock Only Registered Direct Offering "Business Wire" - 10/11/2017 9:55:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/10/2017 7:16:31 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/10/2017 7:02:24 AM
22ndセンチュリーのスペクトラム研究用紙巻きたばこを使用した第3相研究で、超低ニコチンへ... "Business Wire" - 10/9/2017 8:03:00 AM
22nd Century Group Announces $54 Million Common Stock Only Registered Direct Offering "Business Wire" - 10/9/2017 6:30:00 AM
Phase-III-Studie mit Forschungszigaretten der Sorte SPECTRUM® von 22nd Century zeigt, dass eine sofortige Reduzierung auf ei... "Business Wire" - 10/6/2017 3:18:00 PM
L'étude de phase III utilisant les cigarettes SPECTRUM® de 22nd Century démontre qu'une réduction immédiate à un niveau... "Business Wire" - 10/6/2017 2:54:00 PM
Uno studio di fase III, per cui sono state utilizzate le sigarette a scopo di ricerca SPECTRUM® prodotte da 22nd Century, di... "Business Wire" - 10/6/2017 2:29:00 PM
Phase III Study using 22nd Century’s SPECTRUM® Research Cigarettes Demonstrates Immediate Reduction to Very Low Nicotine i... "Business Wire" - 10/6/2017 6:30:00 AM
National Conference on “Tobacco Regulatory Science” to Address FDA’s New Comprehensive Plan for Nicotine Regulation "Business Wire" - 10/3/2017 9:50:00 AM
Cannabis Market Extends across Numerous Industry Segments "NetworkNewsWire" - 10/3/2017 8:45:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/29/2017 5:33:04 PM
Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development "NetworkNewsWire" - 9/28/2017 8:45:00 AM
22ndセンチュリーがブリティッシュ・アメリカン・タバコとの制限的なライセンス契約を解消 "Business Wire" - 9/27/2017 7:55:00 AM
Medical Cannabis Companies Leverage Biosynthesis to Boost Drug Development "NetworkNewsWire" - 9/26/2017 8:45:00 AM
22nd Century von restriktivem Lizenzvertrag mit British American Tobacco befreit "Business Wire" - 9/25/2017 3:34:00 PM
22nd Century dorénavant libérée du contrat de licence restrictif avec British American Tobacco "Business Wire" - 9/25/2017 9:42:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/25/2017 6:31:31 AM
22nd Century Now Free of Restrictive License Agreement with British American Tobacco "Business Wire" - 9/25/2017 6:00:00 AM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
22nd Century to Speak at Global Tobacco & Nicotine Forum "Business Wire" - 9/13/2017 9:55:00 AM
22nd Century Technology is a “Game Changer” "Business Wire" - 8/23/2017 9:50:00 AM
Justfactsmam   Friday, 10/06/17 12:07:42 PM
Re: Atlanta1 post# 37920
Post # of 38408 
"Positive Phase III results are a significant and game-changing breakthrough"...and that's why is sold off so hard this AM?

...market pop on news...but would not say it has concluded it to be "significant"...significant would have been a gap up and continuation of run, not immediate sell-off.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist